abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
19774: HLA-B*5701 Typing Print View
HLA-B*5701      

PRIMARY
1 Whole Blood EDTA 5 (3) mL   Refrigerated - 7 Day(s)/Room Temperature - 7 Day(s)  
ALTERNATE
  Whole Blood Heparin 5 (3) mL   Refrigerated - 7 Day(s)/Room Temperature - 7 Day(s)  
  Whole Blood ACD Sol A 5 (3) mL   Refrigerated - 7 Day(s)/Room Temperature - 7 Day(s)  
  Whole Blood ACD Sol B 5 (3) mL   Room Temperature - 7 Day(s)/Refrigerated - 7 Day(s)  

Abacavir therapy for HIV treatment is associated with significant drug hypersensitivity in approximnately 8% of recipients, with retrospective studies indicating a strong association with the HLA-B*5701 allele. HLA-B*5701 typing can be used for genetic risk stratification prior to initiation of abacavir therapy.

A separate ACD (yellow-top) or EDTA (lavender-top) tube must be
submitted for all HLA testing. If submitted with any other test
requiring an ACD or EDTA tube, please submit a separate tube for this
test. Do not open tube.
Setup Schedule
Sunday-Saturday

Reported (Analytical Time)
8 days

CPT Code
81381

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Reject Criteria: Received frozen Methodology: Sequence Specific Oligonucleotide Probes, Polymerase Chain Reaction Transport Temperature: Room temperature






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database